Phase Scientific’s COVID-19 Test Gets Emergency Use Authorization from FDA

The FDA has granted an Emergency Use Authorization to Phase Scientific International’s Indicaid COVID-19 rapid antigen at-home test.

The Garden Grove, Calif.-based company’s over-the-counter test for home use is intended for the qualitative detection of antigen from the SARS-CoV-2 coronavirus that causes COVID-19 infection.

The test uses self-collected anterior nasal swab samples from people age 14 and up or samples collected by an adult from a child age two to 13. The test is intended for use within six days of the onset of symptoms.